# Voyager Therapeutics, Inc.: Form 8-K, filed Mar 9, 2026

- Company: [Voyager Therapeutics, Inc.](/companies/vygr.md) (CIK 1640266)
- Form: 8-K
- Filed: 2026-03-09
- Accepted by EDGAR: Mar 9, 2026, 16:04 ET
- Period: 2026-03-09
- Accession: 0001104659-26-025201
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1640266/000110465926025201/vygr-20260309x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1640266/000110465926025201/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1640266/000110465926025201/vygr-20260309x8k.htm

Filed Mar 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-025201. Last ingested by Listed: Nov 3, 2026, 18:52 ET. No prices; not investment advice.